ClinicalTrials.Veeva

Menu

Retinal Endo Vascular Surgery for Central Retinal Vein Occlusion

H

Hadassah Medical Center

Status

Unknown

Conditions

Central Retinal Vein Occlusion

Treatments

Procedure: Retinal endo vascular surgery

Study type

Interventional

Funder types

Other

Identifiers

NCT00383773
1yumbo-HMO-CTIL

Details and patient eligibility

About

Patients with Central Retinal Vein Occlusion will undergo vitrectomy, a small needle of about 71 micron will enter a branch retinal vein and TPA will be injected into the obstracted vein.

Full description

Patients with Central Retinal Vein Occlusion less than 6 month duration and reduction of vision to 6/21 will go OCT and FANG examinations.

Patient will be operated vitrectomy, and a branch retinal vein will be punctured by small needle and rTPA 200mcg/ml will be injected to the vein.

Enrollment

10 estimated patients

Sex

All

Ages

18+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • crvo less than 6 month
  • Visual Acuity less than 6/21
  • No prior eye surgery except cataract.

Exclusion criteria

  • Retinal/iris neovascularization

Trial design

Primary purpose

Treatment

Allocation

Non-Randomized

Interventional model

Single Group Assignment

Masking

None (Open label)

Trial contacts and locations

0

Loading...

Central trial contact

Michael Halpert, MD.; Hadas Lemberg, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems